Ipilimumab Retreatment Following Induction Therapy: The Expanded Access Program (EAP) Experience — ASN Events
  1. Schedule
  2. Clinical Research
  3. Posters - Clinical research
  4. Ipilimumab Retreatment Following Induction Therapy: The Expanded Access Program (EAP) Experience

Ipilimumab Retreatment Following Induction Therapy: The Expanded Access Program (EAP) Experience (#182)

Kim Margolin 1 , Omid Hamid 2 , Jeffrey Weber 3 , Anna Pavlick 4 , Stephen Hodi 5 , Asim Amin 6 , Kelly Bennett 7 , Tracy Michener 7 , David Minor 8
  1. University of Washington, Seattle, WA, USA
  2. The Angeles Clinic and Research Institute, Santa Monica, CA, USA
  3. H. Lee Moffitt Cancer Center, Tampa, FL, USA
  4. New York University Cancer Institute, New York, NY, USA
  5. Dana-Farber Cancer Institute, Boston, MA, USA
  6. Levine Cancer Institute, Carolinas Medical Center, Charlotte, NC, USA
  7. Bristol-Myers Squibb, Plainsborough, NJ, United States
  8. California Pacific Melanoma Center, San Francisco, CA, USA
Publish consent withheld